These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10760352)

  • 1. Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.
    Lindeboom JE; Kingma JH; Crijns HJ; Dunselman PH
    Am J Cardiol; 2000 Apr; 85(8):1031-3. PubMed ID: 10760352
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
    Nørgaard BL; Wachtell K; Christensen PD; Madsen B; Johansen JB; Christiansen EH; Graff O; Simonsen EH
    Am Heart J; 1999 Jun; 137(6):1062-9. PubMed ID: 10347332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators.
    Falk RH; Pollak A; Singh SN; Friedrich T
    J Am Coll Cardiol; 1997 Feb; 29(2):385-90. PubMed ID: 9014993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicentre, randomized, double-blind, placebo-controlled study.
    Bianconi L; Castro A; Dinelli M; Alboni P; Pappalardo A; Richiardi E; Santini M
    Eur Heart J; 2000 Aug; 21(15):1265-73. PubMed ID: 10924317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study.
    Singh S; Zoble RG; Yellen L; Brodsky MA; Feld GK; Berk M; Billing CB
    Circulation; 2000 Nov; 102(19):2385-90. PubMed ID: 11067793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a new selective class III antiarrhythmic agent dofetilide in paroxysmal atrial fibrillation or atrial flutter.
    Suttorp MJ; Polak PE; van 't Hof A; Rasmussen HS; Dunselman PH; Kingma JH
    Am J Cardiol; 1992 Feb; 69(4):417-9. PubMed ID: 1734660
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical cardioversion of atrial fibrillation with intravenous dofetilide.
    Sedgwick ML; Lip G; Rae AP; Cobbe SM
    Int J Cardiol; 1995 Apr; 49(2):159-66. PubMed ID: 7628887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
    Vergara G
    Ital Heart J Suppl; 2001 Mar; 2(3):322-3. PubMed ID: 11307794
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of dofetilide, a new class III antiarrhythmic agent, in acute termination of atrial fibrillation or flutter after coronary artery bypass surgery. Dofetilide Post-CABG Study Group.
    Frost L; Mortensen PE; Tingleff J; Platou ES; Christiansen EH; Christiansen N
    Int J Cardiol; 1997 Jan; 58(2):135-40. PubMed ID: 9049678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN
    Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular drugs. Dofetilide.
    Mounsey JP; DiMarco JP
    Circulation; 2000 Nov; 102(21):2665-70. PubMed ID: 11085972
    [No Abstract]   [Full Text] [Related]  

  • 13. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.
    Crijns HJ; Van Gelder IC; Kingma JH; Dunselman PH; Gosselink AT; Lie KI
    Eur Heart J; 1994 Oct; 15(10):1403-8. PubMed ID: 7821320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dofetilide: a new pure class III antiarrhythmic agent.
    Falk RH; Decara JM
    Am Heart J; 2000 Nov; 140(5):697-706. PubMed ID: 11054613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive atrial inotropic effect of dofetilide after cardioversion of atrial fibrillation or flutter.
    DeCara JM; Pollak A; Dubrey S; Falk RH
    Am J Cardiol; 2000 Sep; 86(6):685-8, A8. PubMed ID: 10980226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Quarter of a Century Later: What is Dofetilide's Clinical Role Today?
    Wolbrette DL; Hussain S; Maraj I; Naccarelli GV
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):3-10. PubMed ID: 29940780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
    Coleman CI; Sood N; Chawla D; Talati R; Ghatak A; Kluger J;
    Europace; 2009 Jul; 11(7):892-5. PubMed ID: 19351630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update of the clinical impact and issues surrounding Dofetilide (Tikosyn) therapy.
    Friedman L; Alexander E
    AACN Adv Crit Care; 2006; 17(2):102-8; quiz 109-110. PubMed ID: 16767008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.